BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 31882501)

  • 1. Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry.
    Bratova M; Karlinova B; Skrickova J; Pesek M; Kolek V; Koubkova L; Hrnciarik M; Krejci J; Barinova M; Havel L; Grygarkova I; Brat K
    In Vivo; 2020; 34(1):369-379. PubMed ID: 31882501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin use and lung cancer survival: a population-based study in Norway.
    Brancher S; Støer NC; Weiderpass E; Damhuis RAM; Johannesen TB; Botteri E; Strand TE
    Br J Cancer; 2021 Mar; 124(5):1018-1025. PubMed ID: 33262518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Takamori S; Takada K; Shimokawa M; Jinnnouchi M; Matsubara T; Haratake N; Miura N; Toyozawa R; Yamaguchi M; Takenoyama M; Yoneshima Y; Tanaka K; Okamoto I; Tagawa T; Mori M
    Cancer Immunol Immunother; 2021 Jun; 70(6):1745-1753. PubMed ID: 33389013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.
    Barczi E; Nagy T; Starobinski L; Kolonics-Farkas A; Eszes N; Bohacs A; Tarnoki AD; Tarnoki DL; Müller V
    Thorac Cancer; 2020 Jul; 11(7):1911-1917. PubMed ID: 32401433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non-Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab.
    Augustyn A; Adams DL; He J; Qiao Y; Verma V; Liao Z; Tang CM; Heymach JV; Tsao AS; Lin SH
    Clin Lung Cancer; 2021 May; 22(3):e451-e465. PubMed ID: 32798130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    BMJ Open; 2015 Dec; 5(12):e009419. PubMed ID: 26700282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
    Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
    Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endpoints in phase II trials for advanced non-small cell lung cancer.
    Mandrekar SJ; Qi Y; Hillman SL; Allen Ziegler KL; Reuter NF; Rowland KM; Kuross SA; Marks RS; Schild SE; Adjei AA
    J Thorac Oncol; 2010 Jan; 5(1):3-9. PubMed ID: 19884856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in a cohort of patients with lung cancer: the role of age and gender in prognosis.
    Franceschini JP; Jamnik S; Santoro IL
    J Bras Pneumol; 2017; 43(6):431-436. PubMed ID: 29340491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns in stage III non‑small‑cell lung cancer patients: a population‑based study using German cancer registry data.
    Bedir A; Mehrotra S; Gnüchtel J; Vordermark D; Medenwald D
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15489-15497. PubMed ID: 37648808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of sex inequity in lung-cancer-specific survival.
    Lærum D; Strand TE; Brustugun OT; Gallefoss F; Falk R; Durheim MT; Fjellbirkeland L
    Acta Oncol; 2024 May; 63():343-350. PubMed ID: 38751329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort).
    Lin J; Sun L; Chen H; Chen W; Zhang Z; Cao Y; Lin L
    Integr Cancer Ther; 2023; 22():15347354231185109. PubMed ID: 37493017
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chen Y; MacIsaac S; Young M; Ahodakin M; Jeagal LW; Boucher M; Agulnik J; Boulanger N; Camilleri-Broët S; Ezer N; Gonzalez AV; Owen S; Pepe C; Spicer J; Wang H; White-Dupuis S; Watt L; Grey M; Benedetti A; Khan FA
    CMAJ; 2024 Feb; 196(6):E177-E186. PubMed ID: 38378218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer.
    Børø S; Thoresen S; Boge Brant S; Helland Å
    Acta Oncol; 2023 Dec; 62(12):1642-1648. PubMed ID: 37801361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Danish lung cancer registry: A nationwide validation study.
    Gouliaev A; Ali F; Jakobsen E; Dalton SO; Hilberg O; Rasmussen TR; Christensen NL
    Lung Cancer; 2024 Apr; 190():107527. PubMed ID: 38432026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer prevention and prevention programs.
    Tulinský L
    Cas Lek Cesk; 2023; 162(4):131-135. PubMed ID: 37734938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
    Luciani A; Marra A; Toschi L; Cortinovis D; Fava S; Filipazzi V; Tuzi A; Cerea G; Rossi S; Perfetti V; Rossi A; Giannetta L; Sala L; Finocchiaro G; Pizzutilo EG; Carelli S; Agustoni F; Cergnul M; Zonato S; Siena S; Bidoli P; Ferrari D
    Clin Lung Cancer; 2020 Nov; 21(6):e567-e571. PubMed ID: 32591311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A latent profile analysis of resilience and their relation to differences in sleep quality in patients with lung cancer.
    Li J; Yin YZ; Zhang J; Puts M; Li H; Lyu MM; Wang AN; Chen OY; Zhang JP
    Support Care Cancer; 2024 Feb; 32(3):155. PubMed ID: 38347229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driver and actionable mutations in younger patients with lung cancer - are we searching properly?
    Bratova M; Brat K; Pavlovsky Z; Sana J; Slaby O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Jun; 167(2):152-156. PubMed ID: 37009714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer surgery at present and tendency.
    Honguero-Martínez AF
    Transl Cancer Res; 2022 Dec; 11(12):4220-4222. PubMed ID: 36644170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.